Edition:
India

Vital Therapies Inc (VTL.OQ)

VTL.OQ on NASDAQ Stock Exchange Global Select Market

5.65USD
20 Apr 2018
Change (% chg)

$-0.15 (-2.59%)
Prev Close
$5.80
Open
$5.80
Day's High
$5.82
Day's Low
$5.55
Volume
31,348
Avg. Vol
38,944
52-wk High
$7.20
52-wk Low
$2.25

Chart for

About

Vital Therapies, Inc. is a biotherapeutic company. The Company is focused on developing a human hepatic cell-based treatment targeting acute forms of liver failure. Its product candidate, the ELAD System, is an extracorporeal human allogeneic cellular liver therapy designed to allow the patient's liver to regenerate to a healthy... (more)

Overall

Beta: 5.35
Market Cap(Mil.): $249.02
Shares Outstanding(Mil.): 42.21
Dividend: --
Yield (%): --

Financials

BRIEF-Vital Therapies Announces VTL-308 Reaches Enrollment Target Of 150 Subjects

* VITAL THERAPIES ANNOUNCES VTL-308 REACHES ENROLLMENT TARGET OF 150 SUBJECTS

22 Mar 2018

BRIEF-Vital Therapies Announces Q4 Loss Per Share $0.35

* VITAL THERAPIES ANNOUNCES FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

14 Mar 2018

BRIEF-Vital Therapies Appoints Russell J. Cox As Chief Executive Officer And Board Member

* VITAL THERAPIES APPOINTS RUSSELL J. COX AS CHIEF EXECUTIVE OFFICER AND BOARD MEMBER EFFECTIVE JANUARY 3, 2018

05 Dec 2017

BRIEF-Vital Therapies reports Q3 loss per share $0.30

* Vital therapies announces third quarter 2017 financial results

26 Oct 2017

Earnings vs. Estimates